Table 1. Subject clinical and demographic information.
| HCV cohort | HIV cohort | |||||
| Controls | HCV | HIV/HCV | Controls | HIV a | HIVUD b | |
| N | 17 | 19 | 17 | 11 | 22 | 14 |
| Age (yr) c | 53.4 (7.1) | 56.6 (4.5) | 54.5 (5.2) | 53.0 (4.1) | 49.9 (7.7) | 51.6 (7.2) |
| Ethnicity d | ||||||
| Asian | 1 | 0 | 0 | 1 | 1 | 0 |
| Black | 4 | 6 | 6 | 1 | 6 | 2 |
| Caucasian | 11 | 11 | 10 | 8 | 12 | 11 |
| Hispanic | 1 | 2 | 1 | 1 | 3 | 1 |
| HCV RNA (log10 IU/mL)e | NA | 5.9 (0.8) | 6.2 (0.5) | NA | NA | NA |
| HIV RNA (log10/mL) | NA | NA | undetectable | NA | 5.0 (0.5) | undetectable |
| CD4 Count f | NA | NA | 501 (243) | 1038 (314) | 215 (234) | 515 (261) |
Mean (± SD) except for ethnicity which is count.
a
HIVHVL ≥10,000 copies/ml.
b
HIVUD = undetectable viral load (<50 copies/ml).
c
HIV is younger than HCV (anova p = 0.026, Tukey posthoc p = 0.011).
d
X 2 = 11.9, p = 0.919.
e
Student t test p = 0.103.
f
Anova p<0.001, HIV/HCV, HIV and HIVUD were lower than HIV-Controls (Tukey posthoc p<0.001). HIV was lower than HIV/HCV and HIVUD (Tukey posthoc p<0.05).
NA: not applicable.